Biotech Values

[DewDiligence]

I am not arguing that MNTA's drug will remain off the formulary…

Lovenox’s being left off hospital formularies a la Recothrom is indeed what you were alleging earlier in this thread.

… I really don't want to have an argument with you because we all know that you are always right.

Well done! When your argument is shown to be groundless (hospital P&T committees do not ban FDA-approved generic drugs), you convert your message into a personal attack.

…the question I haven't seen addressed…is what % of Lovenox sales are hospital based…

See #msg-52871590.

…since generic drugs must be "reviewed" by the P&T committees, does the "review" give Sanofi the ability to restructure contracts thereby dropping the price to hospitals?

Both vendors can compete on price if they want to. Duh.